|
51
|
Quatresooz P, Vroome V, Borgers M, Cauwenbergh G, Piérard GE. Novelties in the multifaceted miconazole effects on skin disorders. Expert Opin Pharmacother 2008; 9:1927-34. [DOI: 10.1517/14656566.9.11.1927] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
|
52
|
Barasch A, Griffin AV. Miconazole revisited: new evidence of antifungal efficacy from laboratory and clinical trials. Future Microbiol 2008; 3:265-9. [DOI: 10.2217/17460913.3.3.265] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
In the past 40 years imidazoles have been used extensively in medicine for their antifungal properties. All members of the azole antifungal family inhibit ergosterol biosynthesis. However, the discovery of an additional fungicidal mode of action for miconazole has drawn renewed attention to this compound. In this article we review recent evidence of mechanistic efficacy, as well as clinical trial results of miconazole in new topical formulations.
Collapse
Affiliation(s)
- Andrei Barasch
- Dept of Diagnostic Sciences, University of Alabama at Birmingham, SDB 111, 1530 3rd Avenue S Birmingham, AL 35294-0007, USA
| | - Andreea Voinea Griffin
- Dept of Diagnostic Sciences, University of Alabama at Birmingham, SDB 111, 1530 3rd Avenue S Birmingham, AL 35294-0007, USA
| |
Collapse
|
|
53
|
Current awareness on yeast. Yeast 2008. [DOI: 10.1002/yea.1456] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|